False-positive Aspergillus Antigenemia Due to Blood Product Conditioning Fluids

被引：44
作者：
Martin-Rabadan, Pablo [1 ,2 ,3 ,4 ]
Gijon, Paloma [1 ,4 ]
Fernandez, Roberto Alonso [1 ]
Ballesteros, Monica [5 ]
Anguita, Javier [5 ]
Bouza, Emilio [1 ,2 ,3 ,4 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid 28007, Spain
[2] Univ Complutense Madrid, CIBER Enfermedades Resp CB06 06 0058, Madrid, Spain
[3] Univ Complutense Madrid, Fac Med, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Red Espanola Invest Patol Infecciosa REIPI RD06, Madrid 28007, Spain
[5] Hosp Gen Univ Gregorio Maranon, Dept Clin Hematol, Madrid 28007, Spain
来源：
CLINICAL INFECTIOUS DISEASES | 2012年 / 55卷 / 04期
关键词：
RECEIVING PIPERACILLIN-TAZOBACTAM; GALACTOMANNAN ANTIGENEMIA; ENZYME-IMMUNOASSAY; CROSS-REACTIVITY; CIRCULATING GALACTOMANNAN; INVASIVE ASPERGILLOSIS; PASTOREX ASPERGILLUS; ASSAY REACTIVITY; PLASMA-LYTE; SERUM;
D O I：
10.1093/cid/cis493
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The presence of Aspergillus antigens in blood transfusion components from different manufacturers was analyzed. Galacomannans were found in transfused patients, pooled platelet concentrates, fresh frozen plasma, and packed red cells collected using Fresenius Kabi bags. Galacomannans were also found in blood collection anticoagulant and platelet additive solution from this manufacturer.
引用
收藏
页码：E22 / E27
页数：6
相关论文
共 35 条
  • [11] Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus
    Huang, Yu-Tsung
    Hung, Chien-Ching
    Liao, Chun-Hsing
    Sun, Hsin-Yun
    Chang, Shan-Chwen
    Chen, Yee-Chun
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (09) : 2858 - 2862
  • [12] A case of disseminated histoplasmosis following autologous stem cell transplantation for Hodgkin's lymphoma: an initial misdiagnosis with a false-positive serum galactomannan assay
    Jones, O.
    Cleveland, K. O.
    Gelfand, M. S.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (03) : 281 - 283
  • [13] NEW CAUSE FOR FALSE-POSITIVE RESULTS WITH THE PASTOREX ASPERGILLUS ANTIGEN LATEX AGGLUTINATION-TEST
    KAPPE, R
    SCHULZEBERGE, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (09) : 2489 - 2490
  • [14] Galactomannan detection for invasive aspergillosis in immunocompromized patients
    Leeflang, Mariska M.
    Debets-Ossenkopp, Yvette J.
    Visser, Caroline E.
    Scholten, Rob J. P. M.
    Hooft, Lotty
    Bijlmer, Henk A.
    Reitsma, Johannes B.
    Bossuyt, Patrick M. M.
    Vandenbroucke-Grauls, Christina M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
  • [15] Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis
    Machetti, M.
    Majabo, M. J.
    Furfaro, E.
    Solari, N.
    Novelli, A.
    Cafiero, F.
    Viscoli, C.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) : 806 - 810
  • [16] Bifidobacterial lipoglycan as a new cause for false-positive Platelia Aspergillus enzyme-linked immunosorbent assay reactivity
    Mennink-Kersten, MAS
    Ruegebrink, D
    Klont, RR
    Warris, A
    Gavini, F
    den Camp, HJMO
    Verweij, PE
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) : 3925 - 3931
  • [17] Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection
    Mennink-Kersten, MASH
    Klont, RR
    Warris, A
    Op den Camp, HJM
    Verweij, PE
    [J]. LANCET, 2004, 363 (9405) : 325 - 327
  • [18] Background for different use of antibiotics in different countries
    Llor, C
    Bjerrum, L
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (02) : 333 - 333
  • [19] False-positive Aspergillus galactomannan (GM) assay in histoplasmosis
    Narreddy, Suneetha
    Chandrasekar, Pranatharthi H.
    [J]. JOURNAL OF INFECTION, 2008, 56 (01) : 80 - 81
  • [20] False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment:: does it represent a clinical problem?
    Orlopp, K.
    von Lilienfeld-Toal, M.
    Marklein, G.
    Reiffert, S. M.
    Welter, A.
    Hahn-Ast, C.
    Purr, I.
    Gorschlueter, M.
    Molitor, E.
    Glasmacher, A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 1109 - 1112
1234